ClinicalTrials.gov record
Recruiting No phase listed Observational

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

ClinicalTrials.gov ID: NCT05024929

Public ClinicalTrials.gov record NCT05024929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Targeted Therapy to Increase RAI Uptake in Patients With Metastatic Differentiated Thyroid Cancer

Study identification

NCT ID
NCT05024929
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Children's Hospital of Philadelphia
Other
Enrollment
32 participants

Conditions and interventions

Interventions

  • Whole body scan Procedure

Procedure

Eligibility (public fields only)

Age range
0 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2021
Primary completion
Jan 31, 2031
Completion
Jan 31, 2033
Last update posted
Nov 13, 2025

2021 – 2033

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
University of California San Francisco San Francisco California 94143 Recruiting
Emory University School of Medicine Atlanta Georgia 30322 Recruiting
Boston Children's Hospital Boston Massachusetts 02115 Recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
St. Jude Children's Research Hospital Memphis Tennessee 38105 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
Texas Children's Hospital Houston Texas 77030 Recruiting
Seattle Children's Hospital Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05024929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05024929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →